Using murine studies as well as molecular, and cellular studies in vitro, we demonstrate here that binding of RAGE to mutant KRAS is a direct, positive regulator of HIF1α-dependent hypoxia signaling in pancreatic tumor development. This evidence concerns the gene KRAS and pancreatic neoplasm.